Other languages PMD Device Solutions AB

Equities

PMDS

SE0021513645

Delayed Nasdaq Stockholm Other stock markets 04:35:00 29/04/2024 pm IST			5-day change	1st Jan Change
7.4 ^SEK	-1.99%		-9.76%	-33.12%

11/04	PMD Device Solutions AB (OM:PMDS) acquired Coala Life Inc from Coala-Life Group AB for SEK 3.6 million.	CI
09/04	PMD Device Solutions to Purchase Coala-Life Group's US Unit	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PMD Device Solutions AB (OM:PMDS) acquired Coala Life Inc from Coala-Life Group AB for SEK 3.6 million.	11/04
PMD Device Solutions to Purchase Coala-Life Group's US Unit	09/04
PMD Device Solutions AB Begins Preparation for First German Hospital Pilot	25/03
PMD Device Solutions to Complete Reverse Stock Split; Shares Soar	29/01
Promore Pharma AB will Change its Ticker to PMDS from PROMO	17/01
Promore Pharma AB Announces Board Appointments	29/12
Pmd Device Solutions AB completed the acquisition of Promore Pharma AB (OM:PROMO) in a reverse merger transaction.	29/12
Promore Pharma to Buy PMD Device Solutions via Reverse Acquisition; Stock Skyrockets	29/11
Promore Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11
Promore Pharma Enters Voluntary Liquidation	12/23/12
Promore Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30/23/30
Promore Pharma AB Announces CEO Change	22/23/22
Promore Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23
Promore Pharma AB Auditor Raises 'Going Concern' Doubt	09/23/09
Promore Pharma Reports Outcome from Clinical Phase II Study with Ensereptide	20/23/20
Promore Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	28/23/28
Promore Pharma Reaches the Clean File Milestone in its Phase II Clinical Trial with Ensereptide	27/23/27
Promore Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	29/22/29
Promore Pharma AB Announces Composition of Nomination Committee	23/22/23
Promore Pharma Provides an Update on the Phase II Clinical Trial with Ensereptide	01/22/01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages PMD Device Solutions AB

Equities

PMDS

SE0021513645

Other languages

Filters